Invention Grant
- Patent Title: Tetrahydronaphthyridine somatostatin receptor 5 antagonists
-
Application No.: US15139531Application Date: 2016-04-27
-
Publication No.: US09751878B2Publication Date: 2017-09-05
- Inventor: Shizuo Kasai , Hideki Hirose , Takeshi Yamasaki , Tohru Yamashita , Asato Kina , Yoichi Nishikawa
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP2013-209826 20131007
- Main IPC: C07D471/04
- IPC: C07D471/04

Abstract:
A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.
Public/Granted literature
- US20160237087A1 HETEROCYCLIC COMPOUNDS Public/Granted day:2016-08-18
Information query